Bayer will present three new prespecified subgroup analyses from the pivotal Phase III FINEARTS-HF cardiovascular outcomes trial investigating KERENDI ...

Some patients with advanced heart failure can benefit from the support of a continuous-flow left ventricular assist device (CF-LVAD) to sustain heart function. However, despite improvements managing ...

Drawing inferences from observational data with possible confounding Heart failure is increasing in prevalence and is a major cause of morbidity and mortality worldwide,1 with prevalence ranging from ...

Notable LLMs include GPT-4o by Open AI, Claude 3.5 Sonnet by Anthropic, and Gemini by Google. This scoping review aims to synthesize the current applications and potential uses of LLMs in patient ...

If you are living with heart failure that is no longer responding to conventional heart therapies and your symptoms are getting worse, you may have advanced heart disease. About 6.2 million people are ...

Our updated guideline on menopause, published today, emphasises the importance of an individualised approach and shared decision-making when making choices about treatment for symptoms. Around 5.3 ...

Congestive heart failure (CHF) is the term used to describe what happens when the heart is unable to pump enough blood to meet the body’s needs. (It should not be confused with cardiac arrest in which ...

An artificial intelligence (AI) tool to help doctors identify high-risk heart patients will soon be rolled out on a trial basis in England after a study found it can accurately predict the risk ...

leading to heart failure in many patients—50% of whom do not survive beyond five years. The need for innovative therapies is urgent. The new therapeutic approach aims to improve heart function ...

The FINEARTS-HF trial showed that in patients with symptomatic HF with preserved or mildly reduced LVEF ... Efficacy and Safety of Finerenone Across the Ejection Fraction Spectrum in Heart Failure ...